我国医疗机构药物警戒质量管理规范构建路径研究OA
A Study on the Pathway for Developing Good Pharmacovigilance Practice in Medical Institutions in China
目前我国医疗机构药物警戒质量管理规范(GVP)尚无针对性的统一标准和可实施的参照标准.为进一步规范我国医疗机构药物警戒工作,保障公众用药安全,本研究通过文件与文献研究设计调查问卷,选择我国部分医疗机构开展调研,深入了解医疗机构药物警戒体系构建现状、存在的问题和难点,并提出符合我国国情的医疗机构GVP建设路径,该路径将有助于提升我国医疗机构药物警戒工作的整体水平.
China currently lacks a specific unified standard and an implementable reference standard for good pharmacovigilance practice(GVP)in medical institutions.To further standardize pharmacovigilance activities in Chinese medical institutions and ensure public medication safety,this study designed a questionnaire based on institutional and literature research and conducted a survey of selected medical institutions in China to gain an in-depth understanding of the current status,existing problems,and difficulties in establishing pharmacovigilance systems in medical institutions.Based on the findings,a pathway for developing GVP in medical institutions that is suited to China's national conditions was proposed.This pathway will help improve the overall level of pharmacovigilance activities in Chinese medical institutions.
豆飞燕;霍艳飞;路长飞;孙春晓;黄元;李霞
山东医药大学公共卫生学院山东省药品不良反应监测中心山东省药品不良反应监测中心山东省药品不良反应监测中心山东省药品不良反应监测中心山东省药品不良反应监测中心
医药卫生
药物警戒医疗机构药物警戒质量管理规范药品不良反应报告风险信号识别
pharmacovigilancemedical institutionsgood pharmacovigilance practiceadverse drug reaction reportsrisk signal identification
《中国食品药品监管》 2026 (9)
50-55,6
2025年中国药品监督管理研究会课题(2025-Y-Y-013)
评论